Nearly 950,000 Americans selected a health insurance plan through the state and federal exchanges in February. That brought the total to 4.2 million with one month left in the open enrollment period.
Nearly 950,000 Americans selected a health insurance plan through the state and federal exchanges in February. That brought the total to 4.2 million with one month left in the open enrollment period.
Enrollments decreased by just over 200,000—or 18%—from January, when more than 1.1 million individuals enrolled in commercial plans.
But federal officials expressed optimism that there will be another surge as the March 31 deadline for enrollment approaches. Most people who don't have coverage at that point will face a fine of $95 or 1% of their income, whichever is greater.
In 2006, the Obama administration noted, more than 1 million individuals signed up for plans in the final week of the initial enrollment period for the Medicare prescription drug program. In addition, nearly a quarter of federal employees who opted to change their health benefits in 2012 did so during the last two days of the enrollment period.
Read the full story here: http://bit.ly/1cQqrSJ
Source: Modern Healthcare
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More